nach oben

Erschienen in:

25.08.2020 | Review

Kidney injury as post-interventional complication of TAVI

verfasst von: Michael Morcos, Christof Burgdorf, Andrijana Vukadinivikj, Felix Mahfoud, Joerg Latus, Pontus B. Persson, Vedat Schwenger, Andrew Remppis

Erschienen in: Clinical Research in Cardiology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Transcatheter aortic valve implantation (TAVI) is an accepted treatment approach of aortic stenosis. In the beginning, this technique was executed in high-risk patients only. Today, intermediate-risk patients are also amenable for TAVI, as long as the transfemoral approach is chosen. Numerous predictors have been identified that could lead to periprocedural complications and are defined by patient co-morbidities as well as being inherent to the technical approach. Although vascular complications and postinterventional paravalvular regurgitation have been minimized over the past years by revised technologies and techniques, there is a prevailing individual risk brought about by the specific pathophysiology of the cardiorenal syndrome.

Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363(17):1597–1607. https://doi.org/10.1056/NEJMoa1008232CrossRefPubMed

Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370(19):1790–1798. https://doi.org/10.1056/NEJMoa1400590CrossRefPubMed

Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620. https://doi.org/10.1056/NEJMoa1514616CrossRefPubMed

Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D'Agostino RB Jr, Leon MB (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 387(10034):2218–2225. https://doi.org/10.1016/s0140-6736(16)30073-3CrossRefPubMed

Marino PN, Binda G, Calzaducca E, Panizza A, Ferrari I, Bellacosa I, Ambrosio G (2020) Transcatheter aortic valve replacement acutely improves left ventricular mechanical efficiency in severe aortic stenosis: effects of different phenotypes. Clin Res Cardiol 109(7):819–831. https://doi.org/10.1007/s00392-019-01570-3CrossRefPubMed

Kumar N, Khera R, Fonarow GC, Bhatt DL (2018) Comparison of outcomes of transfemoral versus transapical approach for transcatheter aortic valve implantation. Am J Cardiol 122(9):1520–1526. https://doi.org/10.1016/j.amjcard.2018.07.025CrossRefPubMed

Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochellière R, Doyle D, Masson JB, Gutiérrez MJ, Clavel MA, Bertrand OF, Pibarot P, Rodés-Cabau J (2010) Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 31(7):865–874. https://doi.org/10.1093/eurheartj/ehp552CrossRefPubMed

Siontis GC, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G, Søndergaard L, Jüni P, Windecker S (2016) Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J 37(47):3503–3512. https://doi.org/10.1093/eurheartj/ehw225CrossRefPubMed

Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Nef H, Husser O, Elsässer A, Hamm CW, Möllmann H (2018) Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J 39(8):667–675. https://doi.org/10.1093/eurheartj/ehx688CrossRefPubMed

10.

Hofer F, Hengstenberg C, Goliasch G, Grygier M, Mascherbauer J, Siller-Matula JM (2020) Transcatheter versus surgical aortic valve replacement in low-risk patients: a meta-analysis of randomized trials. Clin Res Cardiol 109(6):761–775. https://doi.org/10.1007/s00392-019-01571-2CrossRefPubMed

11.

Buzzatti N, Sala A, Alfieri O (2020) Comparing traditional aortic valve surgery and transapical approach to transcatheter aortic valve implant. Eur Heart J Suppl 22(Suppl E):E7–e12. https://doi.org/10.1093/eurheartj/suaa050CrossRefPubMedPubMedCentral

12.

Kochman J, Zbroński K, Kołtowski Ł, Parma R, Ochała A, Huczek Z, Rymuza B, Wilimski R, Dąbrowski M, Witkowski A, Scisło P, Grygier M, Lesiak M, Opolski G (2020) Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis utilizing the next-generation fully retrievable and repositionable valve system: mid-term results from a prospective multicentre registry. Clin Res Cardiol 109(5):570–580. https://doi.org/10.1007/s00392-019-01541-8CrossRefPubMed

13.

Mauri V, Deuschl F, Frohn T, Schofer N, Linder M, Kuhn E, Schaefer A, Rudolph V, Madershahian N, Conradi L, Rudolph TK, Schäfer U (2018) Predictors of paravalvular regurgitation and permanent pacemaker implantation after TAVR with a next-generation self-expanding device. Clin Res Cardiol 107(8):688–697. https://doi.org/10.1007/s00392-018-1235-1CrossRefPubMed

14.

Mauri V, Körber MI, Kuhn E, Schmidt T, Frerker C, Wahlers T, Rudolph TK, Baldus S, Adam M, Ten Freyhaus H (2020) Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement. Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01618-9CrossRefPubMedPubMedCentral

15.

Pellegrini C, Rheude T, Trenkwalder T, Mayr NP, Joner M, Kastrati A, Schunkert H, Husser O, Hengstenberg C (2019) One year VARC-2-defined clinical outcomes after transcatheter aortic valve implantation with the SAPIEN 3. Clin Res Cardiol 108(11):1258–1265. https://doi.org/10.1007/s00392-019-01461-7CrossRefPubMedPubMedCentral

16.

Finkelstein A, Steinvil A, Rozenbaum Z, Halkin A, Banai S, Barbash I, Guetta V, Segev A, Danenberg H, Orvin K, Assa HV, Assali A, Kornowski R (2019) Efficacy and safety of new-generation transcatheter aortic valves: insights from the Israeli transcatheter aortic valve replacement registry. Clin Res Cardiol 108(4):430–437. https://doi.org/10.1007/s00392-018-1372-6CrossRefPubMed

17.

Thiele H, Kurz T, Feistritzer HJ, Stachel G, Hartung P, Eitel I, Marquetand C, Nef H, Doerr O, Lauten A, Landmesser U, Abdel-Wahab M, Sandri M, Holzhey D, Borger M, Ince H, Öner A, Meyer-Saraei R, Wienbergen H, Fach A, Frey N, König IR, Vonthein R, Rückert Y, Funkat AK, de Waha-Thiele S, Desch S (2020) Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J 41(20):1890–1899. https://doi.org/10.1093/eurheartj/ehaa036CrossRefPubMed

18.

Lanz J, Kim WK, Walther T, Burgdorf C, Möllmann H, Linke A, Redwood S, Thilo C, Hilker M, Joner M, Thiele H, Conzelmann L, Conradi L, Kerber S, Schymik G, Prendergast B, Husser O, Stortecky S, Heg D, Jüni P, Windecker S, Pilgrim T (2019) Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet 394(10209):1619–1628. https://doi.org/10.1016/s0140-6736(19)32220-2CrossRefPubMed

19.

Attard S, Buttigieg J, Galea S, Mintoff M, Farrugia E, Cassar A (2018) The incidence, predictors, and prognosis of acute kidney injury after transcatheter aortic valve implantation. Clin Nephrol 90(6):373–379. https://doi.org/10.5414/cn109544CrossRefPubMed

20.

Durand E, Avinée G, Gillibert A, Tron C, Bettinger N, Bouhzam N, Gilard M, Verhoye JP, Koning R, Lefevre T, Van Belle E, Leprince P, Iung B, Le Breton H, Eltchaninoff H (2020) Analysis of length of stay after transfemoral transcatheter aortic valve replacement: results from the FRANCE TAVI registry. Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01647-4CrossRefPubMed

21.

Husain-Syed F, McCullough PA, Birk HW, Renker M, Brocca A, Seeger W, Ronco C (2015) Cardio-pulmonary-renal interactions: a multidisciplinary approach. J Am Coll Cardiol 65(22):2433–2448. https://doi.org/10.1016/j.jacc.2015.04.024CrossRefPubMed

22.

Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA, Katz N, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P (2010) Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 31(6):703–711. https://doi.org/10.1093/eurheartj/ehp507CrossRefPubMed

23.

Oguri A, Yamamoto M, Mouillet G, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande JL, Teiger E (2015) Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: results from the FRANCE 2 registry. EuroIntervention 10(9):e1–9. https://doi.org/10.4244/eijv10i9a183CrossRefPubMed

24.

Ferro CJ, Chue CD, de Belder MA, Moat N, Wendler O, Trivedi U, Ludman P, Townend JN (2015) Impact of renal function on survival after transcatheter aortic valve implantation (TAVI): an analysis of the UK TAVI registry. Heart 101(7):546–552. https://doi.org/10.1136/heartjnl-2014-307041CrossRefPubMed

25.

Chen C, Zhao ZG, Liao YB, Peng Y, Meng QT, Chai H, Li Q, Luo XL, Liu W, Zhang C, Chen M, Huang DJ (2015) Impact of renal dysfunction on mid-term outcome after transcatheter aortic valve implantation: a systematic review and meta-analysis. PLoS ONE 10(3):e0119817. https://doi.org/10.1371/journal.pone.0119817CrossRefPubMedPubMedCentral

26.

Schymik G, Bramlage P, Herzberger V, Bergmann J, Conzelmann LO, Würth A, Luik A, Schröfel H, Tzamalis P (2019) Impact of dialysis on the prognosis of patients undergoing transcatheter aortic valve implantation. Am J Cardiol 123(2):315–322. https://doi.org/10.1016/j.amjcard.2018.10.008CrossRefPubMed

27.

Sinning JM, Ghanem A, Steinhäuser H, Adenauer V, Hammerstingl C, Nickenig G, Werner N (2010) Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 3(11):1141–1149. https://doi.org/10.1016/j.jcin.2010.09.009CrossRefPubMed

28.

Voigtländer L, Schewel J, Martin J, Schewel D, Frerker C, Wohlmuth P, Thielsen T, Kuck KH, Schäfer U (2015) Impact of kidney function on mortality after transcatheter valve implantation in patients with severe aortic valvular stenosis. Int J Cardiol 178:275–281. https://doi.org/10.1016/j.ijcard.2014.10.172CrossRefPubMed

29.

Azarbal A, Malenka DJ, Huang YL, Ross CS, Solomon RJ, DeVries JT, Flynn JM, Butzel D, McKay M, Dauerman HL (2019) Recovery of kidney dysfunction after transcatheter aortic valve implantation (from the Northern New England Cardiovascular Disease Study Group). Am J Cardiol 123(3):426–433. https://doi.org/10.1016/j.amjcard.2018.10.042CrossRefPubMed

30.

Linke A, Schlotter F, Haussig S, Woitek FJ, Stachel G, Adam J, Höllriegel R, Lindner A, Mohr FW, Schuler G, Kiefer P, Leontyev S, Thiele H, Borger MA, Holzhey D, Mangner N (2019) Gender-dependent association of diabetes mellitus with mortality in patients undergoing transcatheter aortic valve replacement. Clin Res Cardiol 108(1):39–47. https://doi.org/10.1007/s00392-018-1309-0CrossRefPubMed

31.

Lee K, Ahn JM, Kang DY, Ko E, Kwon O, Lee PH, Lee SW, Kim DH, Kim HJ, Kim JB, Choo SJ, Park DW, Park SJ (2020) Nutritional status and risk of all-cause mortality in patients undergoing transcatheter aortic valve replacement assessment using the geriatric nutritional risk index and the controlling nutritional status score. Clin Res Cardiol 109(2):161–171. https://doi.org/10.1007/s00392-019-01497-9CrossRefPubMed

32.

Siddiqui WJ, Alvarez C, Aslam M, Bakar A, Khan MH, Aslam A, Hanif MO, Hasni SF, Ranganna K, Eisen H, Aggarwal S (2018) Meta-analysis comparing outcomes and need for renal replacement therapy of transcatheter aortic valve implantation versus surgical aortic valve replacement. Am J Cardiol 122(3):468–476. https://doi.org/10.1016/j.amjcard.2018.04.030CrossRefPubMed

33.

Scherner M, Wahlers T (2015) Acute kidney injury after transcatheter aortic valve implantation. J Thorac Dis 7(9):1527–1535. https://doi.org/10.3978/j.issn.2072-1439.2015.06.14CrossRefPubMedPubMedCentral

34.

Kliuk-Ben Bassat O, Finkelstein A, Bazan S, Halkin A, Herz I, Salzer Gotler D, Ravid D, Hakakian O, Keren G, Banai S, Arbel Y (2020) Acute kidney injury after transcatheter aortic valve implantation and mortality risk-long-term follow-up. Nephrol Dial Transpl 35(3):433–438. https://doi.org/10.1093/ndt/gfy264CrossRef

35.

Wystub N, Bäz L, Möbius-Winkler S, Pörner TC, Goebel B, Hamadanchi A, Doenst T, Grimm J, Lehmkuhl L, Teichgräber U, Schulze PC, Franz M (2019) Aortic annulus measurement with computed tomography angiography reduces aortic regurgitation after transfemoral aortic valve replacement compared to 3-D echocardiography: a single-centre experience. Clin Res Cardiol 108(11):1266–1275. https://doi.org/10.1007/s00392-019-01462-6CrossRefPubMed

36.

Asami M, Pilgrim T, Stortecky S, Heg D, Roost E, Windecker S, Hunziker L (2019) Impact of valvular resistance on aortic regurgitation after transcatheter aortic valve replacement according to the type of prosthesis. Clin Res Cardiol 108(12):1343–1353. https://doi.org/10.1007/s00392-019-01469-zCrossRefPubMed

37.

Ozkok A (2019) Cholesterol-embolization syndrome: current perspectives. Vasc Health Risk Manag 15:209–220. https://doi.org/10.2147/vhrm.S175150CrossRefPubMedPubMedCentral

38.

Shishikura D, Kataoka Y, Pisaniello AD, Delacroix S, Montarello JK, Nicholls SJ, Worthley SG (2018) The extent of aortic atherosclerosis predicts the occurrence, severity, and recovery of acute kidney injury after transcatheter aortic valve replacement. Circ Cardiovasc Interv 11(8):e006367. https://doi.org/10.1161/circinterventions.117.006367CrossRefPubMed

39.

Ram P, Mezue K, Pressman G, Rangaswami J (2017) Acute kidney injury post-transcatheter aortic valve replacement. Clin Cardiol 40(12):1357–1362. https://doi.org/10.1002/clc.22820CrossRefPubMedPubMedCentral

40.

Thongprayoon C, Cheungpasitporn W, Srivali N, Ungprasert P, Kittanamongkolchai W, Greason KL, Kashani KB (2015) Acute kidney injury after transcatheter aortic valve replacement: a systematic review and meta-analysis. Am J Nephrol 41(4–5):372–382. https://doi.org/10.1159/000431337CrossRefPubMed

41.

Thongprayoon C, Cheungpasitporn W, Srivali N, Harrison AM, Gunderson TM, Kittanamongkolchai W, Greason KL, Kashani KB (2016) AKI after transcatheter or surgical aortic valve replacement. J Am Soc Nephrol 27(6):1854–1860. https://doi.org/10.1681/asn.2015050577CrossRefPubMed

42.

Van Mieghem NM, Schipper ME, Ladich E, Faqiri E, van der Boon R, Randjgari A, Schultz C, Moelker A, van Geuns RJ, Otsuka F, Serruys PW, Virmani R, de Jaegere PP (2013) Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation 127(22):2194–2201. https://doi.org/10.1161/circulationaha.112.001091CrossRefPubMed

43.

Kapadia SR, Kodali S, Makkar R, Mehran R, Lazar RM, Zivadinov R, Dwyer MG, Jilaihawi H, Virmani R, Anwaruddin S, Thourani VH, Nazif T, Mangner N, Woitek F, Krishnaswamy A, Mick S, Chakravarty T, Nakamura M, McCabe JM, Satler L, Zajarias A, Szeto WY, Svensson L, Alu MC, White RM, Kraemer C, Parhizgar A, Leon MB, Linke A (2017) Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol 69(4):367–377. https://doi.org/10.1016/j.jacc.2016.10.023CrossRefPubMed

44.

Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 60(15):1438–1454. https://doi.org/10.1016/j.jacc.2012.09.001CrossRefPubMed

45.

Ranasinghe MP, Peter K, McFadyen JD (2019) Thromboembolic and bleeding complications in transcatheter aortic valve implantation: insights on mechanisms, prophylaxis and therapy. J Clin Med. https://doi.org/10.3390/jcm8020280CrossRefPubMedPubMedCentral

46.

Cheungpasitporn W, Thongprayoon C, Kashani K (2016) Transcatheter aortic valve replacement: a kidney's perspective. J Renal Inj Prev 5(1):1–7. https://doi.org/10.15171/jrip.2016.01CrossRefPubMedPubMedCentral

47.

Keeley EC, Grines CL (1998) Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol 32(7):1861–1865. https://doi.org/10.1016/s0735-1097(98)00497-5CrossRefPubMed

48.

Aslan G, Afsar B, Sag AA, Camkiran V, Erden N, Yilmaz S, Siriopol D, Incir S, You Z, Garcia ML, Covic A, Cherney DZI, Johnson RJ, Kanbay M (2020) The effect of urine PH and urinary uric acid levels on the development of contrast nephropathy. Kidney Blood Press Res 45(1):131–141. https://doi.org/10.1159/000504547CrossRefPubMed

49.

Feldkamp T, Luedemann M, Spehlmann ME, Freitag-Wolf S, Gaensbacher J, Schulte K, Bajrovic A, Hinzmann D, Hippe HJ, Kunzendorf U, Frey N, Luedde M (2018) Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures. Clin Res Cardiol 107(2):148–157. https://doi.org/10.1007/s00392-017-1166-2CrossRefPubMed

50.

Hayek SS, Leaf DE, Samman Tahhan A, Raad M, Sharma S, Waikar SS, Sever S, Camacho A, Wang X, Dande RR, Ibrahim NE, Baron RM, Altintas MM, Wei C, Sheikh-Hamad D, Pan JS, Holliday MW Jr, Januzzi JL, Weisbord SD, Quyyumi AA, Reiser J (2020) Soluble urokinase receptor and acute kidney injury. N Engl J Med 382(5):416–426. https://doi.org/10.1056/NEJMoa1911481CrossRefPubMedPubMedCentral

51.

Najjar M, Salna M, George I (2015) Acute kidney injury after aortic valve replacement: incidence, risk factors and outcomes. Expert Rev Cardiovasc Ther 13(3):301–316. https://doi.org/10.1586/14779072.2015.1002467CrossRefPubMed

52.

Barbash IM, Ben-Dor I, Dvir D, Maluenda G, Xue Z, Torguson R, Satler LF, Pichard AD, Waksman R (2012) Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement. Am Heart J 163(6):1031–1036. https://doi.org/10.1016/j.ahj.2012.01.009CrossRefPubMed

53.

Frock J, Bierman M, Hammeke M, Reyes A (1994) Atheroembolic renal disease: experience with 22 patients. Nebr Med J 79(9):317–321PubMed

54.

Biancari F, Rosato S, D'Errigo P, Ranucci M, Onorati F, Barbanti M, Santini F, Tamburino C, Santoro G, Grossi C, Covello RD, Ventura M, Fusco D, Seccareccia F (2016) Immediate and intermediate outcome after transapical versus transfemoral transcatheter aortic valve replacement. Am J Cardiol 117(2):245–251. https://doi.org/10.1016/j.amjcard.2015.10.036CrossRefPubMed

55.

Ribeiro HB, Dahou A, Urena M, Carrasco JL, Mohammadi S, Doyle D, Le Ven F, Allende R, Amat-Santos I, Paradis JM, DeLarochellière R, Puri R, Abdul-Jawad Altisent O, del Trigo M, Campelo-Parada F, Pibarot P, Dumont É, Rodés-Cabau J (2015) Myocardial injury after transaortic versus transapical transcatheter aortic valve replacement. Ann Thorac Surg 99(6):2001–2009. https://doi.org/10.1016/j.athoracsur.2015.01.029CrossRefPubMed

56.

Wernly B, Eder S, Navarese EP, Kretzschmar D, Franz M, Alushi B, Beckhoff F, Jung C, Lichtenauer M, Datz C, Schulze PC, Landmesser U, Hoppe UC, Falk V, Lauten A (2019) Transcatheter aortic valve replacement for pure aortic valve regurgitation: "on-label" versus "off-label" use of TAVR devices. Clin Res Cardiol 108(8):921–930. https://doi.org/10.1007/s00392-019-01422-0CrossRefPubMed

57.

Wernly B, Seelmaier C, Leistner D, Stähli BE, Pretsch I, Lichtenauer M, Jung C, Hoppe UC, Landmesser U, Thiele H, Lauten A (2019) Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock-a critical appraisal of current data. Clin Res Cardiol 108(11):1249–1257. https://doi.org/10.1007/s00392-019-01458-2CrossRefPubMed

58.

Wernly B, Zappe AK, Unbehaun A, Sinning JM, Jung C, Kim WK, Fichtlscherer S, Lichtenauer M, Hoppe UC, Alushi B, Beckhoff F, Wewetzer C, Franz M, Kretzschmar D, Navarese E, Landmesser U, Falk V, Lauten A (2019) Transcatheter valve-in-valve implantation (VinV-TAVR) for failed surgical aortic bioprosthetic valves. Clin Res Cardiol 108(1):83–92. https://doi.org/10.1007/s00392-018-1326-zCrossRefPubMed

59.

Miura D, Yamada Y, Kusaba S, Nogami E, Yunoki J, Sakamoto Y, Hikichi Y, Node K, Sakaguchi Y (2019) Influence of preoperative serum creatinine level and intraoperative volume of contrast medium on the risk of acute kidney injury after transfemoral transcatheter aortic valve implantation: a retrospective observational study. BMC Res Notes 12(1):484. https://doi.org/10.1186/s13104-019-4527-2CrossRefPubMedPubMedCentral

60.

Cigarroa RG, Lange RA, Williams RH, Hillis LD (1989) Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86(6 Pt 1):649–652. https://doi.org/10.1016/0002-9343(89)90437-3CrossRefPubMed

61.

McCullough PA, Choi JP, Feghali GA, Schussler JM, Stoler RM, Vallabahn RC, Mehta A (2016) Contrast-induced acute kidney injury. J Am Coll Cardiol 68(13):1465–1473. https://doi.org/10.1016/j.jacc.2016.05.099CrossRefPubMed

62.

Gul I, Zungur M, Tastan A, Okur FF, Damar E, Uyar S, Sahin V, Tavli T (2015) The importance of contrast volume/glomerular filtration rate ratio in contrast-induced nephropathy patients after transcatheter aortic valve implantation. Cardiorenal Med 5(1):31–39. https://doi.org/10.1159/000369943CrossRefPubMed

63.

Madershahian N, Scherner M, Rudolph T, Slottosch I, Grundmann F, Kuhn E, Michels G, Wahlers T (2014) Impact of sex on the risk to develop contrast-induced nephropathy after transcatheter aortic valve implantation. Innovations (Phila) 9(2):87–92. https://doi.org/10.1097/imi.0000000000000052CrossRef

64.

Van Linden A, Kempfert J, Rastan AJ, Holzhey D, Blumenstein J, Schuler G, Mohr FW, Walther T (2011) Risk of acute kidney injury after minimally invasive transapical aortic valve implantation in 270 patients. Eur J Cardiothorac Surg 39(6):835–842. https://doi.org/10.1016/j.ejcts.2010.11.034CrossRefPubMed

65.

Yamamoto M, Hayashida K, Mouillet G, Chevalier B, Meguro K, Watanabe Y, Dubois-Rande JL, Morice MC, Lefèvre T, Teiger E (2013) Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation. JACC Cardiovasc Interv 6(5):479–486. https://doi.org/10.1016/j.jcin.2013.02.007CrossRefPubMed

66.

Vontobel J, Possner M, Schütz P, Müller B, Taramasso M, Binder RK, Haueis S, Attinger-Toller A, Maisano F, Nietlispach F (2015) Early safety outcome following transcatheter aortic valve implantation: is the amount of contrast media used a matter of concern? Swiss Med Wkly 145:w14238. https://doi.org/10.4414/smw.2015.14238CrossRefPubMed

67.

Thongprayoon C, Cheungpasitporn W, Podboy AJ, Gillaspie EA, Greason KL, Kashani KB (2016) The effects of contrast media volume on acute kidney injury after transcatheter aortic valve replacement: a systematic review and meta-analysis. J Evid Based Med 9(4):188–193. https://doi.org/10.1111/jebm.12208CrossRefPubMed

68.

Kane GC, Doyle BJ, Lerman A, Barsness GW, Best PJ, Rihal CS (2008) Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. J Am Coll Cardiol 51(1):89–90. https://doi.org/10.1016/j.jacc.2007.09.019CrossRefPubMed

69.

Davenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, Rodby RA, Wang CL, Weinreb JC (2020) Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the american college of radiology and the national kidney foundation. Radiology 294(3):660–668. https://doi.org/10.1148/radiol.2019192094CrossRefPubMed

70.

Brinkert M, De Boeck B, Petryka J, Buhmann R, Fornaro J, Weberndörfer V, Bossard M, Roos J, Cuculi F, Kobza R (2019) Minimal use of contrast media in patients with severe chronic kidney disease undergoing transcatheter aortic valve implantation. Cardiovasc Med. https://doi.org/10.4414/cvm.2019.02021CrossRef

71.

Hagendorff A, Knebel F, Helfen A, Knierim J, Sinning C, Stöbe S, Fehske W, Ewen S (2020) Expert consensus document on the assessment of the severity of aortic valve stenosis by echocardiography to provide diagnostic conclusiveness by standardized verifiable documentation. Clin Res Cardiol 109(3):271–288. https://doi.org/10.1007/s00392-019-01539-2CrossRefPubMed

72.

Aregger F, Wenaweser P, Hellige GJ, Kadner A, Carrel T, Windecker S, Frey FJ (2009) Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transpl 24(7):2175–2179. https://doi.org/10.1093/ndt/gfp036CrossRef

73.

Nuis RJ, Rodés-Cabau J, Sinning JM, van Garsse L, Kefer J, Bosmans J, Dager AE, van Mieghem N, Urena M, Nickenig G, Werner N, Maessen J, Astarci P, Perez S, Benitez LM, Dumont E, van Domburg RT, de Jaegere PP (2012) Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation. Circ Cardiovasc Interv 5(5):680–688. https://doi.org/10.1161/circinterventions.112.971291CrossRefPubMed

74.

Greco A, Capodanno D (2020) Anticoagulation after transcatheter aortic valve implantation: current status. Interv Cardiol 15:e02. https://doi.org/10.15420/icr.2019.24CrossRefPubMedPubMedCentral

75.

Wang J, Yu W, Zhou Y, Yang Y, Li C, Liu N, Hou X, Wang L (2017) Independent risk factors contributing to acute kidney injury according to updated valve academic research consortium-2 criteria after transcatheter aortic valve implantation: a meta-analysis and meta-regression of 13 studies. J Cardiothorac Vasc Anesth 31(3):816–826. https://doi.org/10.1053/j.jvca.2016.12.021CrossRefPubMed

76.

Nijenhuis VJ, Brouwer J, Delewi R, Hermanides RS, Holvoet W, Dubois CLF, Frambach P, De Bruyne B, van Houwelingen GK, Van Der Heyden JAS, Toušek P, van der Kley F, Buysschaert I, Schotborgh CE, Ferdinande B, van der Harst P, Roosen J, Peper J, Thielen FWF, Veenstra L, Chan Pin Yin D, Swaans MJ, Rensing B, van 't Hof AWJ, Timmers L, Kelder JC, Stella PR, Baan J, Ten Berg JM, (2020) Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med 382(18):1696–1707. https://doi.org/10.1056/NEJMoa1915152CrossRefPubMed

77.

Geis NA, Kiriakou C, Chorianopoulos E, Uhlmann L, Katus HA, Bekeredjian R (2018) NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation. Clin Res Cardiol 107(9):799–806. https://doi.org/10.1007/s00392-018-1247-xCrossRefPubMed

78.

Sedaghat A, Sinning JM, Vasa-Nicotera M, Ghanem A, Hammerstingl C, Grube E, Nickenig G, Werner N (2013) The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol 102(11):821–829. https://doi.org/10.1007/s00392-013-0596-8CrossRefPubMed

79.

Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U (2012) EuroSCORE II. Eur J Cardiothorac Surg 41(4):734–744. https://doi.org/10.1093/ejcts/ezs043CrossRefPubMed

80.

Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR (1992) Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J 67(3):236–239. https://doi.org/10.1136/hrt.67.3.236CrossRefPubMedPubMedCentral

81.

Shastri S, Sarnak MJ (2010) Cardiovascular disease and CKD: core curriculum 2010. Am J Kidney Dis 56(2):399–417. https://doi.org/10.1053/j.ajkd.2010.03.019CrossRefPubMed

82.

Tarrass F, Benjelloun M, Zamd M, Medkouri G, Hachim K, Benghanem MG, Ramdani B (2006) Heart valve calcifications in patients with end-stage renal disease: analysis for risk factors. Nephrology (Carlton) 11(6):494–496. https://doi.org/10.1111/j.1440-1797.2006.00696.xCrossRef

83.

Kobrin DM, McCarthy FH, Herrmann HC, Anwaruddin S, Kobrin S, Szeto WY, Bavaria JE, Groeneveld PW, Desai ND (2015) Transcatheter and surgical aortic valve replacement in dialysis patients: a propensity-matched comparison. Ann Thorac Surg 100(4):1230–1236. https://doi.org/10.1016/j.athoracsur.2015.05.039CrossRefPubMed

84.

Kuno T, Takagi H, Ando T, Ueyama H, Fujisaki T, Kodaira M, Numasawa Y, Briasoulis A, Hayashida K (2020) Short- and long-term outcomes in dialysis patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis. Can J Cardiol. https://doi.org/10.1016/j.cjca.2020.01.015CrossRefPubMed

85.

De Backer O, Butt JH, Wong YH, Torp-Pedersen C, Terkelsen CJ, Nissen H, Fosbøl EL, Køber L, Søndergaard L (2020) Early and late risk of ischemic stroke after TAVR as compared to a nationwide background population. Clin Res Cardiol 109(7):791–801. https://doi.org/10.1007/s00392-019-01565-0CrossRefPubMed

86.

Fox H, Büttner S, Hemmann K, Asbe-Vollkopf A, Doss M, Beiras-Fernandez A, Moritz A, Zeiher AM, Scheuermann E, Geiger H, Fichtlscherer S, Hauser IA, Lehmann R (2013) Transcatheter aortic valve implantation improves outcome compared to open-heart surgery in kidney transplant recipients requiring aortic valve replacement. J Cardiol 61(6):423–427. https://doi.org/10.1016/j.jjcc.2013.01.016CrossRefPubMed

87.

Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC (2008) Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 148(4):284–294. https://doi.org/10.7326/0003-4819-148-4-200802190-00007CrossRefPubMed

88.

Seeliger E, Lenhard DC, Persson PB (2014) Contrast media viscosity versus osmolality in kidney injury: lessons from animal studies. Biomed Res Int 2014:358136. https://doi.org/10.1155/2014/358136CrossRefPubMedPubMedCentral

89.

Barbanti M, Gulino S, Capranzano P, Immè S, Sgroi C, Tamburino C, Ohno Y, Attizzani GF, Patanè M, Sicuso R, Pilato G, Di Landro A, Todaro D, Di Simone E, Picci A, Giannetto G, Costa G, Deste W, Giannazzo D, Grasso C, Capodanno D, Tamburino C (2015) Acute kidney injury with the renalguard system in patients undergoing transcatheter aortic valve replacement: the protect-tavi trial (prophylactic effect of furosemide-induced diuresis with matched isotonic intravenous hydration in transcatheter aortic valve implantation). JACC Cardiovasc Interv 8(12):1595–1604. https://doi.org/10.1016/j.jcin.2015.07.012CrossRefPubMed

90.

Visconti G, Focaccio A, Donahue M, Golia B, Marzano A, Donnarumma E, Ricciardelli B, Selvetella L, Marino L, Briguori C (2016) RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation. EuroIntervention 11(14):e1658–1661. https://doi.org/10.4244/eijv11i14a317CrossRefPubMed

91.

Latus J, Schwenger V, Schlieper G, Reinecke H, Hoyer J, Persson PB, Remppis BA, Mahfoud F (2020) Kontrastmittelinduzierte akute Nierenschädigung–Konsensuspapier der Arbeitsgemeinschaft Herz–Niere“ der Deutschen Gesellschaft für Kardiologie–Herz-und Kreislaufforschung e. V. und der Deutschen Gesellschaft für Nephrologie e. V. Kardiologe Der Kardiologe. https://doi.org/10.1007/s12181-020-00411-2CrossRef

Titel: Kidney injury as post-interventional complication of TAVI
verfasst von: Michael Morcos
Christof Burgdorf
Andrijana Vukadinivikj
Felix Mahfoud
Joerg Latus
Pontus B. Persson
Vedat Schwenger
Andrew Remppis
Publikationsdatum: 25.08.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Research in Cardiology / Ausgabe 3/2021
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-020-01732-8

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Kidney injury as post-interventional complication of TAVI

Abstract

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

The diagnostic benefit of 16S rDNA PCR examination of infective endocarditis heart valves: a cohort study of 146 surgical cases confirmed by histopathology

Impact of cancer history on clinical outcome in patients undergoing transcatheter edge-to-edge mitral repair

Transcatheter or surgical aortic valve implantation in chronic dialysis patients: a German Aortic Valve Registry analysis

Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients

Transcatheter aortic valve replacement from a single vascular access: an ultra-minimalist approach

Simultaneous ballooning and transcatheter valve implantation as a back-up maneuver in bicuspid aortic valve with horizontal aorta

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie